A rating of 46 puts Mersana Therapeutics Inc (MRSN) near the middle of the Biotechnology industry according to InvestorsObserver. Mersana Therapeutics Inc's score of 46 means it scores higher than 46% of stocks in the industry. Mersana Therapeutics Inc also received an overall rating of 42, putting it above 42% of all stocks. Biotechnology is ranked 47 out of the 148 industries.
MRSN has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on MRSN!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 42 means the stock is more attractive than 42 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Mersana Therapeutics Inc Stock Today?
Mersana Therapeutics Inc (MRSN) stock is trading at $1.58 as of 12:53 PM on Monday, Nov 20, a gain of $0.03, or 1.61% from the previous closing price of $1.55. The stock has traded between $1.52 and $1.73 so far today. Volume today is less active than usual. So far 1,038,749 shares have traded compared to average volume of 2,174,158 shares.
Click Here to get the full Stock Report for Mersana Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
